Tepper wins an American Society of Clinical Oncology (ASCO) 2011 Statesman Award

Award recognizes a career of oncology-related voluntarism and patient care.

Dr. Joel Tepper

Joel E. Tepper, MD, the Hector MacLean Distinguished Professor of Cancer Research in the Department of Radiation Oncology wasbe one of twenty recipients of the American Society of Clinical Oncology (ASCO) 2011 Statesman Award.

The award, presented at ASCO’s Annual Meeting in early June in Chicago, IL, recognizes the extraordinary dedication of ASCO members for their voluntary efforts that benefit the Society, the specialty of oncology, and the patients served by the profession.  Each year the award is given tovolunteers who have given 20 or more cumulative years of service to the Society.

Dr. Tepper shares the award with another outstanding Lineberger Comprehensive Cancer Center member, Richard M. Goldberg, MD, Distinguished Professor and Chief of the UNC Division of Hematology/Oncology, and Physician-in-Chief of the NC Cancer Hospital.

Higginson honored with Clinical Oncology Fellow award

Higginson honored with Clinical Oncology Fellow award

Dr. Higginson awarded with first annual Lineberger Clinical Fellow Award established to recognize UNC cancer trainees' outstanding accomplishments in both clinical and research endeavors.

Higginson honored with Clinical Oncology Fellow award - Read More…

Alston promoted to CyberKnife Coordinator

Tonia Alston accepts coordinator position effective September 4, 2012.

Alston promoted to CyberKnife Coordinator - Read More…

Adams, Varia, Zeman honored

Robert Adams gets Award of Excellence; Mahesh Varia, Elaine Zeman induced as Fellows

Adams, Varia, Zeman honored - Read More…

Chen paper: IMRT better than Protons/CRT

Chen paper: IMRT better than Protons/CRT

In comparing IMRT, Proton and conformal therapies, they conclude that IMRT is better than conventional conformal radiation therapy (CRT) for reducing certain side effects and preventing cancer recurrence.

Chen paper: IMRT better than Protons/CRT - Read More…

Chang and Zhou awarded GO grant from NCI

Chang and Zhou awarded GO grant from NCI

Prestigious $2M Grand Opportunity grant for a novel micro-RT brain tumor irradiator.

Chang and Zhou awarded GO grant from NCI - Read More…

Chang awarded patent

This novel device has the potential to accelerate cancer cell biology research worldwide.

Chang awarded patent - Read More…

Filed under: